Xylem (NYSE:XYL) Given “Outperform” Rating at Oppenheimer

Xylem (NYSE:XYL)‘s stock had its “outperform” rating reaffirmed by investment analysts at Oppenheimer in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $160.00 target price on the industrial products company’s stock, down from their previous target price of $165.00. Oppenheimer’s target price would indicate a potential upside of 30.34% from the company’s current price.

XYL has been the subject of several other reports. William Blair began coverage on shares of Xylem in a research report on Monday, January 26th. They issued an “outperform” rating for the company. Stifel Nicolaus decreased their price target on shares of Xylem from $178.00 to $175.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Royal Bank Of Canada dropped their price objective on Xylem from $176.00 to $162.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 11th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Finally, Barclays decreased their target price on Xylem from $166.00 to $156.00 and set an “overweight” rating for the company in a research report on Wednesday, February 11th. Ten investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $155.54.

Xylem Trading Up 2.7%

XYL stock traded up $3.26 during midday trading on Wednesday, reaching $122.76. The company’s stock had a trading volume of 677,495 shares, compared to its average volume of 1,850,426. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.28 and a current ratio of 1.62. The stock has a fifty day simple moving average of $128.81 and a two-hundred day simple moving average of $138.08. Xylem has a 1 year low of $100.47 and a 1 year high of $154.27. The firm has a market capitalization of $29.85 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 1.66 and a beta of 1.17.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. Xylem’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.18 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. On average, equities research analysts predict that Xylem will post 4.65 EPS for the current year.

Xylem announced that its board has approved a stock repurchase plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to buy up to 4.8% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On Xylem

Hedge funds and other institutional investors have recently modified their holdings of the business. AQR Capital Management LLC boosted its position in Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after acquiring an additional 3,900 shares in the last quarter. NewEdge Advisors LLC raised its position in shares of Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after acquiring an additional 132 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Global Retirement Partners LLC bought a new stake in Xylem during the second quarter valued at about $213,000. Finally, Mackenzie Financial Corp boosted its position in Xylem by 0.3% during the second quarter. Mackenzie Financial Corp now owns 41,601 shares of the industrial products company’s stock valued at $5,382,000 after purchasing an additional 128 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.